|
1
|
Marioni G, Marchese-Ragona R, Cartei G,
Marchese F and Staffieri A: Current opinion in diagnosis and
treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bugni JM, Meira LB and Samson LD:
Alkylation-induced colon tumorigenesis in mice deficient in the
Mgmt and Msh6 proteins. Oncogene. 28:734–741. 2009. View Article : Google Scholar
|
|
3
|
Meng CF, Zhu XJ, Peng G and Dai DQ: Role
of histone modifications and DNA methylation in the regulation of
O6-methylguanine-DNA methyltransferase gene expression in human
stomach cancer cells. Cancer Invest. 28:331–339. 2010. View Article : Google Scholar
|
|
4
|
McCabe MT, Brandes JC and Vertino PM:
Cancer DNA methylation: molecular mechanisms and clinical
implications. Clin Cancer Res. 15:3927–3937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim YJ, Yoon HY, Kim SK, et al: EFEMP1 as
a novel DNA methylation marker for prostate cancer: array-based DNA
methylation and expression profiling. Clin Cancer Res.
17:4523–4530. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang X, Li Z, Ma J, et al: DNA
methylation of NDRG2 in gastric cancer and its clinical
significance. Dig Dis Sci. 58:715–723. 2013. View Article : Google Scholar
|
|
7
|
Wozniak RJ, Klimecki WT, Lau SS, Feinstein
Y and Futscher BW: 5-Aza-2′-deoxycytidine-mediated reductions in
G9A histone methyltransferase and histone H3 K9 di-methylation
levels are linked to tumor suppressor gene reactivation. Oncogene.
26:77–90. 2007. View Article : Google Scholar
|
|
8
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar :
|
|
9
|
O’Sullivan B and Shah J: New TNM staging
criteria for head and neck tumors. Semin Surg Oncol. 21:30–42.
2003. View Article : Google Scholar
|
|
10
|
Samudio-Ruiz SL and Hudson LG: Increased
DNA methyltransferase activity and DNA methylation following
epidermal growth factor stimulation in ovarian cancer cells.
Epigenetics. 7:216–224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kondo Y, Shen L, Cheng AS, et al: Gene
silencing in cancer by histone H3 lysine 27 trimethylation
independent of promoter DNA methylation. Nat Genet. 40:741–750.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Socha MJ, Said N, Dai Y, et al: Aberrant
promoter methylation of SPARC in ovarian cancer. Neoplasia.
11:126–135. 2009.PubMed/NCBI
|
|
13
|
Wu LP, Wang X, Li L, et al: Histone
deacetylase inhibitor depsipeptide activates silenced genes through
decreasing both CpG and H3K9 methylation on the promoter. Mol Cell
Biol. 28:3219–3235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grewal SI and Moazed D: Heterochromatin
and epigenetic control of gene expression. Science. 301:798–802.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang X, Zhang S, Ma J, et al: Association
of NDRG1 gene promoter methylation with reduced NDRG1 expression in
gastric cancer cells and tissue specimens. Cell Biochem Biophys.
66:93–101. 2013. View Article : Google Scholar
|
|
16
|
Agathanggelou A, Cooper WN and Latif F:
Role of the Ras-association domain family 1 tumor suppressor gene
in human cancers. Cancer Res. 65:3497–3508. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fahrner JA, Eguchi S, Herman JG and Baylin
SB: Dependence of histone modifications and gene expression on DNA
hypermethylation in cancer. Cancer Res. 62:7213–7218.
2002.PubMed/NCBI
|
|
18
|
Liu J, Zhu X, Xu X and Dai D: DNA promoter
and histone H3 methylation downregulate NGX6 in gastric cancer
cells. Med Oncol. 31:8172014. View Article : Google Scholar
|
|
19
|
Dong W, Wang L and Shen R: MYO5B is
epigenetically silenced and associated with MET signaling in human
gastric cancer. Dig Dis Sci. 58:2038–2045. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chakraborty AK, de Sousa JF, Chakraborty
D, et al: GnT-V expression and metastatic phenotypes in
macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC:
evidence for methylation sensitive, extragenic regulation of GnT-V
transcription. Gene. 374:166–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng DF, Razvi M, Chen H, et al: DNA
hypermethylation regulates the expression of members of the
Mu-class glutathione S-transferases and glutathione peroxidases in
Barrett’s adenocarcinoma. Gut. 58:5–15. 2009. View Article : Google Scholar
|
|
22
|
Fuks F, Hurd PJ, Deplus R and Kouzarides
T: The DNA methyltransferases associate with HP1 and the SUV39H1
histone methyltransferase. Nucleic Acids Res. 31:2305–2312. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin W and Dent SY: Functions of
histone-modifying enzymes in development. Curr Opin Genet Dev.
16:137–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kondo Y: Epigenetic cross-talk between DNA
methylation and histone modifications in human cancers. Yonsei Med
J. 50:455–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schneider BG, Peng DF, Camargo MC, et al:
Promoter DNA hypermethylation in gastric biopsies from subjects at
high and low risk for gastric cancer. Int J Cancer. 127:2588–2597.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tost J: DNA methylation: an introduction
to the biology and the disease-associated changes of a promising
biomarker. Methods Mol Biol. 507:3–20. 2009. View Article : Google Scholar
|
|
27
|
Tong JD, Jiao NL, Wang YX, Zhang YW and
Han F: Downregulation of fibulin-3 gene by promoter methylation in
colorectal cancer predicts adverse prognosis. Neoplasma.
58:441–448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhi Y, Chen J, Zhang S, et al:
Down-regulation of CXCL12 by DNA hypermethylation and its
involvement in gastric cancer metastatic progression. Dig Dis Sci.
57:650–659. 2012. View Article : Google Scholar
|
|
29
|
Hu Q, Yu L, Chen R, Wang YL, et al:
5-aza-2′-deoxycytidine improves the sensitivity of endometrial
cancer cells to progesterone therapy. Int J Gynecol Cancer.
22:951–959. 2012. View Article : Google Scholar : PubMed/NCBI
|
